Condition: Geographic Atrophy · Macular Degeneration · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Retina Associates Southwest PC | Tucson, Arizona, United States | Recruiting |
| Retina Consultants of Orange County | Fullerton, California, United States | Recruiting |
| Shiley Eye Institute Jacobs Retina Center | La Jolla, California, United States | Recruiting |
| California Retina Consultants | Oxnard, California, United States | Recruiting |
| California Eye Medical Specialists | Pasadena, California, United States | Recruiting |
| Retina Consultants San Diego | Poway, California, United States | Recruiting |
| Bay Area Retina Associates | Walnut Creek, California, United States | Recruiting |
| Retina Group of Florida | Fort Lauderdale, Florida, United States | Recruiting |
| VitreoRetinal Associates, PA | Gainesville, Florida, United States | Recruiting |
| Retina Specialty Institute | Pensacola, Florida, United States | Recruiting |
| Retina Vitreous Associates of Florida | St. Petersburg, Florida, United States | Recruiting |
| Georgia Retina | Marietta, Georgia, United States | Recruiting |
+ 92 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06635148